Skip to main content
/
MediXall Group, Inc. (MDXL)
OTCMKTS · Delayed Price · Currency is USD
0.0035
+0.0002 (6.06%)
At close: Jan 28, 2025

MediXall Group Revenue

In the year 2023, MediXall Group had annual revenue of $309.42K with 422.07% growth. MediXall Group had revenue of $94.50K in the quarter ending December 31, 2023, with 366.81% growth.

Revenue
309.42K
Revenue Growth
+422.07%
P/S Ratio
1.44
Revenue / Employee
44.20K
Employees
7
Market Cap
758.35K

Revenue Chart

Created with Highcharts 11.4.8MediXall Group Revenue - Annual2.69K​2.69K15.00K​15.00K59.27K​59.27K309.42K​309.42K20192020202120222023-100K200K300K

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023309.42K250.15K422.07%
Dec 31, 202259.27K44.27K295.25%
Dec 31, 202115.00K--
Dec 31, 2020---
Dec 31, 20192.69K827.0044.51%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.18B
SS Innovations International 16.04M
Veradigm 1.53B
Elite Pharmaceuticals 70.00M
Glass House Brands 188.29M
Northwest Biotherapeutics 1.60M
Silence Therapeutics 43.26M
BioStem Technologies 210.49M
Revenue Rankings

MediXall Group News

More News